Table 2.
Characteristics No. (%) | All patients N= 139 |
|
---|---|---|
Gender | ||
Female | 31 (22) | |
Male | 108 (78) | |
Age, mean (range), y | 70 (48-85) | |
Histology | ||
Squamous cell carcinoma | 101 (73) | |
Adenocarcinoma | 38 (27) | |
Localisation | ||
Suprabifurcal | 60 (43) | |
Infrabifurcal | 48 (35) | |
Overlapping | 31 (22) | |
Length | ||
≤8 cm | 122 (88) | |
>8cm | 17 (12) | |
Lymph node metastases, cN+ | ||
Yes | 116 (84) | |
No | 23 (17) | |
ECOG-PS at palliative treatment | ||
0-1 | 39 (28) | |
2-3 | 100 (72) | |
Treatment | ||
EBRT | 65 (47) | |
BT | 46 (33) | |
EBRT+BT | 28 (20) | |
Dysphagia score | ||
0 | 0 (0) | |
1 | 42 (30) | |
2 | 60 (43) | |
3 | 30 (22) | |
4 | 7 (5) |
ECOG-PS: Eastern Cooperative Oncology Group performance status; EBRT: external beam radiotherapy; BT: brachytherapy